Proliferative Effects of Erythropoietin on Human Endometrium

Trial Profile

Proliferative Effects of Erythropoietin on Human Endometrium

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Epoetin alfa (Primary)
  • Indications Anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Feb 2017 New trial record
    • 23 Feb 2017 Planned Primary Completion date has been changed from 10 April 2017 to 25 mar 2017.
    • 23 Feb 2017 Planned end date has been changed from 20 April 2017 to 30 mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top